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Introduction
Biomonitoring has been called “the gold 
standard” for chemical exposure assessment 
in environmental epidemiology (Sexton et al. 
2004), and use of biomonitoring in such 
studies has expanded rapidly. The direct 
measurement of the chemical of interest in 
biological samples from individuals within 
a study population provides powerful infor-
mation in the study of chemical exposures. 
However, valid interpretation of the biomoni-
toring data, particularly in the study of poten-
tial associations with health outcomes, will be 
enhanced by increasing understanding of the 
various physiological characteristics, temporal 
and pharmacokinetic issues, and other factors 
that might potentially affect the relationship 
between measured biomarker concentration 
and relevant chemical exposure levels.
The U.S. National Health and Nutrition 
Examination Survey (NHANES) cross-
sectional data sets have proven to be a rich 
database allowing development of hypoth-
eses regarding exposures to environmental 
chemicals (as reflected in biomonitoring data) 
and health outcomes. One area of particular 
interest has been the evaluation of chemi-
cals with potential endocrine activity. Several 
studies have examined the NHANES data 
to assess potential relationships between 
outcomes such as obesity and urinary 
concentrations of various chemicals or their 
metabolites (Bhandari et al. 2013; Carwile 
and Michels 2011; Eng et al. 2013; Hatch 
et al. 2008; LaKind et al. 2012; Melzer et al. 
2010, 2012; Trasande et al. 2012; Twum 
and Wei 2011). In these analyses, urinary 
concentrations are implicitly assumed to 
be direct surrogates for relevant chemical 
exposure levels.
Identification of relevant exposure metrics 
and interpretation of urinary analyte concen-
trations in that context requires consideration 
of mode of action of the chemical of interest 
as well as the pharmacokinetic and physi-
ological factors that influence the relationship 
between exposure and urinary concentra-
tions. For chemical risk assessment, systemic 
exposures as assessed in nanograms chemical 
per kilogram body weight per day are often 
used as the metric of interest. However, for 
chemicals producing toxicity directly to a 
tissue at the route of entry, other exposure 
metrics such as non-body weight–adjusted 
exposure in nanograms per day, may also be 
of interest. Interpretation of exposures for 
either of these metrics using urinary concen-
trations of analytes requires assumptions 
or data about urinary flow rates. In studies 
relying on urinary biomarker concentrations 
for exposure characterization, including most 
analyses of biomarker concentrations and 
health outcomes based on the NHANES data 
sets, biomarker concentrations are usually 
regarded as direct surrogates for exposure 
level. Equation 1 shows that daily chemical 
intake per kilogram body weight (BW) 
(intake rates, IR milligram per kilogram BW) 
is estimated based on measured concentration 
(C) using generic assumptions about average 
urinary flow rates (V24) and a direct propor-
tionality factor that represents the fraction of 
ingested compound excreted in urine [FUE; 
reviewed by Angerer et al. (2011)]:
 IR = (C × V24)/(FUE × BW). [1]
Although sources of random variation 
in urinary concentrations from spot urine 
samples, apart from differences in exposure 
level, are often acknowledged, potential 
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Background: Urinary analyte concentrations are affected both by exposure level and by urinary 
flow rate (UFR). Systematic variations in UFR with demographic characteristics or body mass 
index (BMI) could confound assessment of associations between health outcomes and biomarker 
concentrations.
oBjectives: We assessed patterns of UFR (milliliters per hour) and body weight–adjusted UFR 
(UFRBW; milliliters per kilogram per hour) across age, sex, race/ethnicity, and BMI category in the 
NHANES (National Health and Nutrition Examination Survey) 2009–2012 data sets.
Methods: Geometric mean (GM) UFR and UFRBW were compared across age-stratified (6–11, 
12–19, 20–39, 40–59, and ≥ 60 years) subgroups (sex, race/ethnicity, and BMI category). Patterns 
of analyte urinary concentration or mass excretion rates (nanograms per hour and nanograms per 
kilogram per hour BW) were assessed in sample age groups for case study chemicals bisphenol A 
and 2,5-dichlorophenol.
results: UFR increased from ages 6 to 60 years and then declined with increasing age. UFRBW 
varied inversely with age. UFR, but not UFRBW, differed significantly by sex (males > females 
after age 12 years). Differences in both metrics were observed among categories of race/ethnicity. 
UFRBW, but not UFR, varied inversely with BMI category and waist circumference in all age 
groups. Urinary osmolality increased with increasing BMI. Case studies demonstrated different 
exposure–outcome relationships depending on exposure metric. Conventional hydration status 
adjustments did not fully address the effect of flow rate variations.
conclusions: UFR and UFRBW exhibit systematic variations with age, sex, race/ethnicity, and 
BMI category. These variations can confound assessments of potential exposure–health outcome 
associations based on urinary concentration. Analyte excretion rates are valuable exposure metrics in 
such assessments.
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sources of systematic bias are generally not 
discussed or recognized. One source of varia-
tion that has long been recognized is the 
substantial variation in urinary flow rate as 
a reflection of hydration status (Barr et al. 
2005; Garde et al. 2004). Such variation in 
flow leads to variation in analyte concentra-
tion in urine due to varying dilution of urine, 
and the flow rate can vary substantially within 
individuals, within and across days, as well as 
across individuals.
As a result, a number of approaches to 
“correcting” urinary concentrations for hydra-
tion status have been used. The most common 
of these is creatinine correction, in which 
the measured concentration of the analyte is 
divided by the concentration of creatinine in 
the urine. This is done with the understanding 
that creatinine excretion in urine occurs at a 
rate that is less variable than the rate of urinary 
flow in volume excreted per time. However, it 
has been recognized that creatinine excretion 
rates differ systematically across the popula-
tion, with children excreting less creatinine 
per kilogram body weight than adults (Barr 
et al. 2005; Remer et al. 2002), and with 
systematic differences between lean and obese 
individuals and across different racial and 
ethnic groups, partly attributable to varia-
tions in dietary pattern (Mage et al. 2008). 
Because of these systematic differences, assess-
ment of potential associations between health 
outcomes and creatinine-corrected biomarker 
concentrations are subject to potential 
confounding or systematic bias if the health 
outcome is also independently associated with 
these characteristics.
Other sources of variation also exist, and 
are generally treated as sources of random vari-
ation, including variation within and between 
individuals and within day due to rapid elimi-
nation kinetics and timing of sampling relative 
to exposure (Aylward et al. 2012). This source 
of variation is not addressed in the present 
analysis but has been analyzed elsewhere 
(Aylward et al. 2012; Pleil and Sobus 2013; 
Preau et al. 2010; Tan et al. 2007).
The most recent surveys released by 
NHANES (2009–2010,  2011–2012) 
collected data from each participant on 
urinary flow, which directly addresses the 
issue of hydration status without requiring 
use of an indirect surrogate such as creati-
nine concentration. Specifically, the time 
and volume of the complete void(s) collected 
at the mobile examination center (MEC) 
were measured, and participants were asked 
to record the time of their last urinary void 
before the void collected at the MEC. The 
measured urinary composite void volume (V, 
milliliters), the recorded time since last void 
(t, hours), the participant body weight (BW, 
kilograms) and the urinary concentration of 
an analyte (C, nanograms per milliliter) can 
be used to calculate directly the urinary excre-
tion rate (ER) of the analyte over the time 
period covered by the collected urinary void 
in nanograms per hour:
 ER(ng/hr) = (C × V )/t,  [2]
or in nanograms per kilogram BW per hour:
 ER(ng/kg-hr) = (C × V )/(t × BW ). [3]
The calculated analyte excretion rate 
directly accounts for hydration status varia-
tions by incorporating the actual urinary 
flow rate (volume per time either absolute 
or per kilogram body weight), rather than 
an assumed “average” flow rate or surrogate 
factor such as creatinine concentration. This 
calculation represents the “true” excretion 
rate of the analyte in nanograms per hour or 
nanograms per kilogram BW per hour over 
the time period covered by the urinary spot 
sample. The factor representing the propor-
tionality constant between the actual excre-
tion rate and the measured concentration of 
any analyte in urine for a given sample is the 
urinary flow rate (UFR, milliters per hour) or 
the body weight–adjusted urinary flow rate 
(UFRBW, milliters per kilogram per hour).
In the ideal case, even with random 
variation in urinary flow rates, urinary 
concentrations would be proportionally 
and consistently related to analyte excretion 
rates without systematic differences by age, 
sex, race/ethnicity, or characteristics such as 
body mass index (BMI). That is, ideally, the 
UFR or UFRBW term in Equations 2 and 3, 
although variable within and between individ-
uals, would be relatively consistent on average 
across different population groups and charac-
teristics without systematic differences. In that 
case, urinary concentrations could be used as 
a direct and unbiased surrogate for excretion 
rate, and therefore for intake rates, without 
confounding due to systematic differences in 
urinary flow. However, if systematic differ-
ences in urinary flow rate among groups exist, 
differences in urinary concentrations would 
be affected not only by differences in analyte 
excretion rate due to differences in exposure 
levels, but also by systematic differences in 
urinary flow rates. This could confound inter-
pretation of observed associations between 
outcomes and urinary concentrations in 
the NHANES data set and in other studies 
relying on urinary biomarker concentration 
as an exposure metric. This is particularly true 
if the urinary flow rates systematically vary 
along with the health outcome of interest 
(e.g., obesity).
In this paper we provide an assessment of 
patterns in UFR and UFRBW (milliters per 
hour and milliters per kilogram per hour) by 
age, sex, race/ethnicity, and BMI based on the 
NHANES 2009–2010 and 2011–2012 data 
sets. We also provide brief case studies demon-
strating the use of unadjusted concentration, 
creatinine-adjusted concentration, osmolality, 
and calculated excretion rates (Equations 2 
and 3) to examine patterns in exposure to 
bisphenol A (BPA) and 2,5-dichlorophenol 
(25DCP) across population groups, with 
particular focus on patterns with BMI. The 
results can inform the design and analysis of 
studies examining the relationship between 
exposure to chemicals (as measured by 
urinary biomonitoring data) and potential 
health outcomes.
Methods
This analysis relies on data collected during 
the 2009–2010 and 2011–2012 NHANES 
survey cycles. Data sets on urinary flow, demo-
graphic variables, body measures, urinary 
creatinine concentration, urinary osmolality, 
and environmental phenols were down-
loaded from the NHANES website [Centers 
for Disease Control and Prevention (CDC) 
2014]. Information on participant consent and 
descriptions of the laboratory methods used 
for the determination of creatinine, osmolality, 
and chemical measures are available at the 
NHANES website (CDC 2014). All statis-
tical analyses were conducted incorporating 
the NHANES survey design characteristics 
and appropriate population weights in Stata IC 
12.1 (StataCorp, College Station, TX).
Urinary flow rates. Urinary flow rate 
was measured in participants ages 6 and 
above attending an examination at one of 
the MECs as part of NHANES during years 
2009–2012. The entire urinary void volume 
was measured and the time of sample collec-
tion was recorded at the MEC. In addition, 
participants were asked to record the time 
of their last urinary void before the void 
collected at the MEC. This information 
was requested in the forms filled out by the 
participant before the MEC appointment and 
was also prompted via phone call the evening 
before the appointment (for documentation, 
see http://www.cdc.gov/nchs/nhanes/nhanes_
questionnaires.htm). Finally, when the initial 
void collected was of insufficient volume for 
the clinical and laboratory analyses, up to 
two additional voids were collected during 
the MEC visit, with volumes and timing 
measured, and all collected samples were 
composited. All laboratory analyses were 
conducted on the composited sample.
The composite UFR (milliters per hour) 
was calculated as quotient of the total volume 
collected and the total time covered by all 
collected voids, and the UFRBW was calcu-
lated by dividing the sample UFR (milliters 
per hour) by the measured body weight (kilo-
grams) for each participant. The geometric 
means (GM) [95% confidence interval (CI)] 
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of the UFR and UFRBW were calculated for 
each age group (6–11, 12–19, and ≥ 20 years) 
and among adults in age groups 20–39, 
40–59, and ≥ 60 years; by sex; category of 
BMI (< 20, 20 to < 25, 25 to < 30, and ≥ 30); 
and race as coded by NHANES (Mexican 
American, non-Hispanic white, non-Hispanic 
black, and other). Statistical significance of 
differences in the GMs compared with the 
reference category for each parameter was 
assessed using the adjusted Wald test, which 
is a modified version of the F-test that, as 
implanted in Stata, takes into account the 
survey design characteristics of the data set.
Use of BMI as a marker for obesity 
depends on the measured body weight, as 
does the UFRBW. Therefore, the relation-
ship between UFR or UFRBW and obesity 
was assessed using a second, independent, 
measure of obesity: waist circumference. 
Osmolality was also measured in NHANES 
using freezing point depression osmometry 
(for details on laboratory methods, see http://
www.cdc.gov/nchs/nhanes). Osmolality is a 
measure of urine concentration, and associa-
tions between urine osmolality and BMI were 
also examined.
Analyte case studies. The effect of consid-
eration of urinary flow rate on exposure assess-
ment was illustrated through examination 
of alternative methods of using the available 
biomarker concentration data to characterize 
exposure. We selected chemicals for which 
previous outcome association analyses relying 
on patterns in urinary concentration had been 
published and for which urinary concen-
tration data were already released for the 
NHANES 2009–2010 and 2011–2012 data 
sets. BPA has been the subject of a number 
of analyses using previous NHANES data 
sets (without available flow information) 
and was deemed to be of significant interest 
(Bhandari et al. 2013; Carwile and Michels 
2011; Casey and Neidell 2013; Eng et al. 
2013; LaKind et al. 2012; Melzer et al. 2010, 
2012; Trasande et al. 2012). Twum and Wei 
(2011) reported on associations between 
urinary concentrations of 25DCP and obesity 
in children and adolescents, and we selected 
this as a second example. Urinary concen-
tration data were assessed here for BPA and 
25DCP for selected age groups. We examined 
the impact of quantifying exposures in terms 
of unadjusted concentrations, creatinine- or 
osmolality-adjusted concentrations, and calcu-
lated analyte mass excretion rate (nanograms 
per hour or nanograms per kilogram per hour) 
on patterns across BMI category.
We calculated GM analyte concentra-
tions by BMI category within age groups for 
the example analyses based on unadjusted 
measured concentration, creatinine-corrected 
and osmolality-adjusted concentrations, and 
based on excretion rate (equations 2 and 3). 
Creatinine-corrected concentrations (Ccr-adj) 
were calculated as
 Ccr-adj = Cvol /Ccr, [4]
where Cvol is the measured volume-based 
concentration of the analyte in nanograms 
per milliter, and Ccr is the creatinine concen-
tration in grams per milliter. Osmolality-
adjusted concentrations (Cosm-adj) were 
calculated as (Frederiksen et al. 2013)
 Cosm-adj = (Cvol × Osmmed)/Osmmeas,  [5]
where Osmmed is the median population 
osmolality, and Osmmeas is the measured 
osmolality in a specific sample. Urinary 
specific gravity is also sometimes used to 
correct for hydration status, but this was not 
measured in the NHANES 2009–2012 data 
sets and so is not assessed here.
Results
UFR data were avai lable for 14,631 
participants in the 2009–2012 NHANES 
cycles. Summary statistics on the distri-
butions of collected void volumes and 
t ime covered by the col lected urine 
samples by age group are presented in 
Table 1. The GMs for UFR and UFRBW 
across the entire 2009–2012 NHANES 
data set were 47.76 mL/hr (95% CI: 
45.64, 49.98 mL/hr) and 0.65 mL/hr-kg 
(95% CI: 0.63, 0.67 mL/hr-kg), respectively. 
Patterns of UFR and UFRBW with age 
were assessed visually and notable differences 
among age groups were observed (Figure 1). 
UFR as a function of age rises through child-
hood and into adulthood and then declines in 
older adults. UFRBW exhibits a steep decline 
in children < 12 years of age, with a more 
gradual decline with age after 12 years. As a 
result, subsequent assessments relied upon 
age stratification.
Figure 1 demonstrates that a few samples 
displayed very low or very high flow rates. 
Conventionally, such extreme values are 
omitted from assessment of biomonitoring 
data sets (when UFR data are available) 
(Santonen et al. 2014). It is possible that these 
values reflect errors in reported time since last 
void or void collection volumes. However, 
because the collections are spot samples rather 
than 24-hr collections, substantial variation 
in UFR is possible. The results reported here 
were not affected by trimming the data set to 
remove the most extreme values.
UFR was significantly greater in males 
than in females for all age categories except 
children 6–11 years of age (Table 2). In 
contrast, UFRBW did not differ between 
males and females at any age (Table 3).
Complex patterns by race and ethnicity 
were observed for both UFR and UFRBW 
(Tables 2 and 3). Compared with non-
Hispanic white (NHW) participants, 
Mexican-American (MA) and non-Hispanic 
black (NHB) adult participants had signifi-
cantly lower UFR and UFRBW. UFR and 
UFRBW in NHB children and adolescents 
were also significantly lower than in NHW 
children and adolescents. UFRBW was 
lower in MA children than NHW children. 
Participants identified as “other” did not 
Table 1. Summary statistics (mean and key percentiles) for collected void volumes and time covered by 
collected void volumes.
Age group (years) n Mean p5 p25 p50 p75 p95
First collected void volume (mL)
6–11 2,014 93 13 36 69 128 259
12–19 2,251 122 17 44 94 178 324
20–39 3,627 128 19 50 103 182 324
40–59 3,499 120 21 54 96 163 309
≥ 60 3,356 101 14 41 78 138 264
Composite collected volume (mL)
6–11 2,014 110 30 55 89 146 267
12–19 2,251 150 41 74 124 205 337
20–39 3,627 155 48 82 129 210 341
40–59 3,499 136 40 69 111 178 325
≥ 60 3,356 122 34 63 99 159 287
Time since previous void for first collected void (min)
6–11 1,993 178 48 90 141 213 444
12–19 2,231 192 47 87 149 222 582
20–39 3,604 159 43 81 128 192 375
40–59 3,491 138 42 75 117 170 296
≥ 60 3,334 135 42 76 116 173 277
Total time covered by composited voids (min)
6–11 2,014 194 58 110 165 225 459
12–19 2,251 214 60 118 178 245 582
20–39 3,627 182 55 104 160 218 386
40–59 3,499 153 46 88 131 191 317
≥ 60 3,356 159 52 94 145 206 301
p, percentile.
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differ significantly from NHW participants in 
any age group for either metric.
With respect to BMI, UFR in children 
increased in the middle two BMI categories 
compared with the lowest BMI category, and 
was markedly lower in the BMI > 30 category 
compared with BMI < 20 (Table 2). For 
adolescents and adults, UFR was essentially 
independent of BMI category (Table 2). 
This implies that urinary flow does not 
increase proportionally with body weight 
after childhood. In contrast, UFRBW varied 
inversely with BMI category in all age groups 
(Table 3). The magnitude of decrease from 
the lowest (BMI < 20) to highest category 
Figure 1. UFR (mL/hr) (A) and UFRBW (mL/hr-kg) (B) as a function of age in the NHANES 2009–2012 data sets. Blue line is the fractional polynomial fit with 95% CI 
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Table 2. GM UFR (mL/hr) from NHANES 2009–2012 by age group, sex, race/ethnic group, and BMI categories.
Mean
6–11 years 12–19 years 20–39 years 40–59 years ≥ 60 years
GM (95% CI) p-Valuea GM (95% CI) p-Valuea GM (95% CI) p-Valuea GM (95% CI) p-Valuea GM (95% CI) p-Valuea
All 33.3 (31.4, 35.3) < 0.001b 42.5 (40.7, 44.4) < 0.001b 51.1 (48.5, 53.8) Reference 51.9 (50.2, 53.6) 0.6b 43.2 (41.5, 44.9) < 0.001b
Sex
Male (reference) 33.6 (31.6, 35.9) Reference 44.5 (42.0, 47.2) Reference 54.5 (51.9, 57.3) Reference 55.1 (52.5, 57.9) Reference 47.4 (44.7, 50.2) Reference
Female 33.0 (30.3, 35.9) 0.7 40.5 (38.1, 43.0) 0.02 47.9 (44.7, 51.4) < 0.001 49.0 (47.2, 50.8) < 0.001 40.0 (37.9, 42.3) < 0.001
Race/ethnic group
Mexican American 31.5 (28.7, 34.7) 0.1 41.9 (38.7, 45.5) 0.3 44.8 (41.5, 48.3) < 0.001 43.8 (40.4, 47.4) < 0.001 37.5 (33.0, 42.6) 0.02
Non-Hispanic White 35.0 (32.0, 38.3) Reference 44.3 (41.3, 47.6) Reference 55.7 (52.3, 59.2) Reference 54.9 (52.7, 57.2) Reference 44.3 (42.3, 46.5) Reference
Non-Hispanic Black 31.1 (28.1, 34.4) 0.09 36.9 (33.8, 40.2) < 0.001 38.8 (36.9, 40.9) < 0.001 42.5 (40.3, 44.9) < 0.001 37.9 (35.9, 40.0) < 0.001
Other 33.9 (28.9, 39.8) 0.7 43.9 (39.7, 48.7) 0.9 52.9 (48.7, 57.5) 0.2 52.3 (45.9, 59.5) 0.5 41.6 (36.4, 47.6) 0.3
BMI 
< 20 (reference) 32.2 (30.0, 34.6) Reference 40.6 (37.0, 44.5) Reference 46.0 (39.5, 53.6) Reference 54.4 (44.7, 66.3) Reference 39.0 (32.3, 47.2) Reference
20 to < 25 37.3 (32.9, 42.3) 0.04 42.4 (39.6, 45.5) 0.4 52.6 (48.4, 57.1) 0.09 56.5 (52.1, 61.1) 0.7 41.4 (37.4, 45.8) 0.6
25 to < 30 38.4 (33.5, 44.1) 0.03 43.5 (39.7, 47.6) 0.3 52.1 (47.6, 57.1) 0.2 52.1 (48.8, 55.6) 0.7 45.3 (41.7, 49.3) 0.2
≥ 30 25.7 (19.8, 33.3) 0.1 45.2 (40.7, 50.1) 0.1 49.7 (46.9, 52.7) 0.3 48.9 (47.1, 50.8) 0.3 42.6 (40.5, 44.9) 0.4
ap-Values present comparison to reference group within each age stratum for each categorization (sex, race/ethnic group, or BMI category), except as otherwise indicated. 
bCompared with ages 20–39 years.
Table 3. GM UFRBW (mL/hr-kg) from NHANES 2009–2012 by age group, sex, race/ethnic group, and BMI categories.
Mean
6–11 years 12–19 years 20–39 years 40–59 years ≥ 60 years
GM (95% CI) p-Valuea GM (95% CI) p-Valuea GM (95% CI) p-Valuea GM (95% CI) p-Valuea GM (95% CI) p-Valuea
All 1.01 (0.95, 1.07) < 0.001b 0.67 (0.63, 0.70) 0.5b 0.65 (0.62, 0.69) Reference 0.64 (0.62, 0.66) 0.4b 0.56 (0.53, 0.58) < 0.001b
Sex
Male (reference) 1.04 (0.97, 1.11) Reference 0.66 (0.61, 0.71) Reference 0.64 (0.61, 0.67) Reference 0.62 (0.59, 0.65) Reference 0.56 (0.53, 0.59) Reference
Female 0.98 (0.89, 1.07) 0.3 0.67 (0.63, 0.72) 0.7 0.66 (0.61, 0.72) 0.3 0.66 (0.63, 0.68) 0.04 0.55 (0.52, 0.59) 0.7
Race/ethnic group
Mexican American 0.94 (0.85, 1.03) 0.02 0.67 (0.62, 0.72) 0.5 0.57 (0.53, 0.62) < 0.001 0.55 (0.51, 0.60) < 0.001 0.49 (0.43, 0.56) 0.05
Non-Hispanic White 1.08 (0.98, 1.19) Reference 0.70 (0.64, 0.75) Reference 0.71 (0.66, 0.75) Reference 0.67 (0.64, 0.70) Reference 0.57 (0.54, 0.60) Reference
Non-Hispanic Black 0.87 (0.78, 0.97) 0.005 0.55 (0.51, 0.59) < 0.001 0.46 (0.43, 0.49) < 0.001 0.49 (0.46, 0.51) < 0.001 0.47 (0.44, 0.49) < 0.001
Other 1.09 (0.95, 1.25) 0.9 0.72 (0.64, 0.82) 0.6 0.75 (0.69, 0.83) 0.1 0.75 (0.65, 0.87) 0.1 0.61 (0.52, 0.71) 0.3
BMI
 < 20 (reference) 1.12 (1.05, 1.21) Reference 0.84 (0.77, 0.91) Reference 0.87 (0.75, 1.00) Reference 1.06 (0.86, 1.31) Reference 0.80 (0.68, 0.95) Reference
20 to < 25 0.85 (0.75, 0.96) < 0.001 0.69 (0.64, 0.74) < 0.001 0.81 (0.75, 0.87) 0.4 0.87 (0.80, 0.95) 0.06 0.66 (0.60, 0.73) 0.04
25 to < 30 0.65 (0.57, 0.75) < 0.001 0.57 (0.52, 0.63) < 0.001 0.66 (0.61, 0.72) 0.004 0.66 (0.62, 0.70) < 0.001 0.59 (0.55, 0.64) 0.004
≥ 30 0.43 (0.35, 0.52) < 0.001 0.46 (0.41, 0.51) < 0.001 0.49 (0.46, 0.52) < 0.001 0.48 (0.46, 0.50) < 0.001 0.45 (0.43, 0.48) < 0.001
ap-Values present comparison with reference group within each age stratum for each categorization (sex, race/ethnic group, or BMI category), except as otherwise indicated. 
bCompared with ages 20–39 years.
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was nearly 3-fold in the youngest age group 
(from 1.12 to 0.43 mL/hr-kg, p < 0.001), 
and nearly 2-fold in adolescents (0.84 to 
0.46 mL/hr-kg, p < 0.001) and adults (e.g., 
1.06 to 0.48 mL/hr-kg, p < 0.001, in adults 
ages 40–59 years). The magnitude of this 
variation across BMI categories is larger 
than the magnitude of differences observed 
among racial and ethnic groups or across age 
groups. This inverse relationship is a natural 
consequence of the observation that UFR 
is relatively independent of BMI, at least in 
adolescents and adults: In a given stratum, 
as body weight and therefore BMI increase, 
the rate of urinary flow per kilogram body 
weight declines.
Results from the analysis of urinary flow 
rate as a function of waist circumference (WC) 
were consistent with the patterns observed 
with BMI. UFR was essentially independent 
of WC, whereas UFRBW declines as WC 
increases (Figure 2A and 2B, respectively).
Analyte case studies. BPA and BMI in 
adults. GM urinary concentrations of BPA in 
adults from the NHANES 2009–2012 survey 
data (n = 3,395) increased monotonically and 
significantly with BMI category (Figure 3). 
The association disappears when two methods 
of correction for hydration status, creatinine 
and osmolality adjustment, are applied to the 
measured urinary BPA concentrations. When 
assessed on the basis of mass excretion rate 
(nanograms BPA per hour), the pattern of 
excretion rate by BMI category looks similar 
to the pattern by concentration. However, on 
the basis of body weight–adjusted excretion 
rate, a statistically significant association is 
again observed, but reversed in direction, with 
the lowest mass excretion rate for BPA in the 
highest BMI category.
25DCP and BMI in children and 
adolescents. GM urinary concentrations 
of 25DCP in children and adolescents also 
trended upward with BMI category, doubling 
between the lowest and highest BMI cate-
gories (Figure 4). After applying hydration 
status adjustment using creatinine, the trend 
became nonsignificant. The trend remained 
when osmolality adjustment was applied. GM 
mass excretion rates (nanograms per hour) 
showed a similar pattern to that for unad-
justed concentration, whereas there was no 
Figure 2. UFR (mL/hr) (A), and UFRBW (mL/hr-kg) (B) as a function of waist circumference in adults in the NHANES 2009–2012 data sets. The blue line is the frac-
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Figure 3. GM (95% CI) urinary BPA concentration, creatinine-adjusted concentration, osmolality-adjusted 
concentration, and mass excretion rates [(ng/hr)/100 or ng/hr-kg] by BMI category based on urinary spot 
samples from adults in the NHANES 2009–2012 data sets. Mass excretion rates were plotted divided by 100 
to allow comparison of pattern on the same numerical scale with the other metrics. 
































Figure 4. GM (95% CI) urinary 25DCP concentration, creatinine-adjusted concentration, osmolality-
adjusted concentration, and mass excretion rates [(ng/hr)/100 or ng/hr-kg] by BMI category in children 
and adolescents in the NHANES 2009–2012 data sets. Mass excretion rates were plotted divided by 100 to 
allow comparison of pattern on the same numerical scale with the other metrics. 
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trend in body weight–adjusted excretion rates 
across BMI categories.
Discussion
The collection of UFR data in the NHANES 
examinations beginning in 2009 allows 
an expanded understanding of factors to 
be considered in the valid interpretation 
of urinary biomarker data as a metric of 
exposure. The conceptual model for inter-
preting urinary biomonitoring data for rapidly 
metabolized compounds is based on the 
recognition that many of these compounds 
are eliminated (as parent compound or 
metabolite) primarily in urine, with urinary 
excretion of analyte (parent or metabolite) 
directly proportional to the rate of intake 
of parent compound, on average. Urinary 
concentrations are usually treated, implicitly 
or explicitly, as direct surrogates for intake 
rates. Variations in hydration status have been 
recognized as an important source of vari-
ability in measured urinary concentrations, 
but this has conventionally been assumed to 
be a source of random error. The collection of 
UFR information in the post-2008 NHANES 
cycles provides a powerful tool for assessing 
this assumption. The analyses presented here 
show that there are strong and systematic 
varia tions in UFR as a function of age, sex, 
and race or ethnicity, and strong and system-
atic variations in UFBBW as a function of age, 
race or ethnicity, and BMI.
Because measured urinary concentrations 
are functions of both analyte excretion rate, 
which is related to chemical exposure levels, 
and UFR, which is not, systematic variations 
in UFR associated with health outcomes of 
interest can directly confound the assess-
ment of associations between urinary analyte 
concentrations and that health outcome. In 
the initial analyses presented here, the relative 
independence of UFR and the resulting 
systematic inverse variation of UFRBW with 
BMI is directly relevant to the evaluation of 
potential associations between urinary analyte 
concentrations, and not only markers for 
obesity but also diseases for which obesity 
may be a risk factor.
Conventional methods for adjustment for 
hydration status, such as creatinine correction, 
did not fully address the systematic variations 
in UFR observed here. Creatinine excretion 
itself has been recognized to vary systematically 
in the population, with well-recognized differ-
ences among excretion rates in young children, 
young adults, and older adults (on a per 
kilogram BW basis as well as on an absolute 
basis); differences between sexes; varia tion with 
BMI, and variations with dietary pattern and 
renal health status (Barr et al. 2005; Mage 
et al. 2008; Remer et al. 2002). As a result, 
Barr et al. (2005) have recommended that 
urinary creatinine concentration be entered as 
an independent variable in regression analyses 
rather than applied as a hydration status 
“correction” factor to measured urinary analyte 
concentrations.
However, the systematic variations 
in UFRBW with BMI observed in the 
NHANES data set are not necessarily related 
to hydration status per se. That is, it is not 
necessarily true that overweight and obese 
individuals are “dehydrated” relative to lean 
individuals. Total body water and water 
replacement requirements are most directly 
related to fat-free mass. Increases in fat mass 
have much smaller impacts on total body 
water and fluid balance than increases in 
fat-free mass (Chumlea et al. 1999, 2005; 
Wang et al. 1999), and urinary output rates 
(milliliters per hour) do not increase linearly 
with body weight. Thus, methods such as 
adjustment for specific gravity or creatinine 
concentration, which implicitly address physi-
ologically “concentrated” or “dilute” urine, 
may not address the reduced UFR compared 
with lean individuals (per kilogram body 
weight) that would be “normal” in obese 
subjects. This is supported by the examination 
of urinary osmolality data from NHANES. 
Urinary osmolality—a measure of particles 
per mass of urine, and thus of general urinary 
concentration—increases monotonically with 
BMI in all age categories (p < 0.001, data 
not shown). This suggests that physiologi-
cally, urine is more concentrated on average 
in persons with higher BMI, and that this is 
physiologically normal and does not represent 
a deficient hydration status.
The systematic variation of UFR with 
BMI could lead to “reverse causation,” 
in which the health outcome (obesity, or 
diseases that can be directly associated with 
obesity) influences the analyte concentration 
through reduced UFR, rather than analyte 
concentration causing the health outcome. 
The further systematic variation of flow rate 
among categories of race and ethnicity also 
should be considered in design and analysis 
of biomonitoring-based studies. Other factors 
not directly considered here (e.g., fasting 
time, time of day, time since last void) may 
also have impacts on UFR that should be 
assessed for systematic sources of variation in 
interpretation of biomarker concentrations. 
However, assessment of exposure on the 
basis of analyte excretion rate in nanograms 
per kilogram body weight per hour rather 
than urinary analyte concentration directly 
accounts for such variations. UFRs have 
also recently been shown to partially or fully 
account for apparent associations between 
low urinary cadmium concentrations and 
urinary protein levels (Akerstrom et al. 2013). 
Further consideration of urinary excretion of 
target analytes, urinary flow, and potential 
interrelationships with outcomes of interest 
should be applied in studies using urinary 
biomarkers of exposure.
Consideration of UFR and calculated 
analyte excretion rate does not address other 
sources of variation in biomarker concen-
trations or excretion rate. For example, the 
impact of rapid pharmacokinetics of these 
compounds, and therefore the impact of 
the time between exposure and sampling on 
both urinary concentration and analyte excre-
tion rate, have been recognized. As a result, 
assessment of within- and between-person 
variability in biomarker concentrations and 
evaluation of the potential magnitude of such 
variation has become an important compo-
nent of such studies (Aylward et al. 2012, 
2014; Preau et al. 2010; Ye et al. 2011).
Finally, reliance on analyte mass excretion 
rate calculated as the product of urinary flow 
rate and analyte concentration for exposure 
classification does not reduce the importance 
of having a conceptual model of the exposure 
pathways, routes, and timing, and hypotheses 
regarding the likely pattern of analyte excre-
tion rates. For example, in studies in which 
BMI is an outcome of interest, the route of 
exposure may result in systematic variations 
in urinary analyte excretion as a function of 
BMI. For chemicals for which the predomi-
nant exposure pathway is dietary, food intake 
rates may scale reasonably directly with body-
weight, and therefore, the null hypothesis 
might suggest that equal food intakes (per 
kilogram body weight) across BMI categories 
would result in increasing intake of contami-
nant (nanograms per day) as BMI increases, 
and therefore increasing mass excretion rates 
in nanograms per day with BMI. However, 
on the basis of nanograms per kilogram per 
day, intakes and excretion rates might be 
expected to be similar across BMI catego-
ries. In contrast, if the primary exposure 
pathway is inhalation, for the same concentra-
tion in air, persons with higher BMI may 
inhale less air per kilogram body weight and 
therefore less compound per kilogram body 
weight (Brochu et al. 2014), and so might be 
expected to have lower analyte excretion rates 
(nanograms per kilogram per day) compared 
with lean individuals.
The differences in absolute pattern of 
concentrations and excretion rates across BMI 
categories for the two case-study chemicals 
presented here may be attributable to such 
differences in exposure patterns. However, in 
both cases, the pattern across BMI categories 
for concentration versus body weight–adjusted 
excretion rate changed in the same direction, 
reducing or reversing the positive association 
between concentration and BMI category.
This analysis presents an initial evalua-
tion of patterns in UFR across age, sex, race/
ethnicity, and BMI using simple compari son 
of geometric mean flow rates in the NHANES 
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2009–2012 data sets. These data sets provide 
a wealth of data that can and should be 
examined with further evaluations to inform 
the understanding of the effect of physi-
ological and sampling characteristics on urine 
spot samples. Such factors might include, but 
not be limited to, time of day of sampling, 
reported fasting time, glomerular filtra-
tion rate, and detailed patterns with age for 
children in the 6- to 11-year-old age range. 
In particular, an examination of glomerular 
filtration rate and urinary flow characteristics 
can potentially inform how patterns in UFR, 
and resulting patterns in urinary concentration 
of analytes may be related to blood concentra-
tions of the same chemical, at least for those 
chemicals that are excreted via filtration. The 
data sets can also be used to inform distribu-
tions and covariation assumptions included 
in detailed physiologically based pharmaco-
kinetic modeling that addresses urinary excre-
tion of chemicals. In addition, the patterns 
in UFR presented here may also influence 
the interpretation of urinary concentrations 
observed in populations monitored for occu-
pational exposures in relationship to Biological 
Exposure Indices (American Conference of 
Governmental and Industrial Hygienists 
2014) or other  occupational biomonitoring 
guidelines.
The strong and significant systematic 
varia tions of UFR observed across categories 
of age, race/ethnicity, and BMI suggest that 
variation in urinary analyte concentrations due 
to “hydration status” should not be assumed 
to be random with respect to health outcomes 
or populations of interest. Further, conven-
tional methods for addressing “hydration 
status” are insufficient for accounting for the 
observed systematic variation in flow rates. 
The case studies presented here are not meant 
to be exhaustive assessments of the associations 
reported between various analytes and BMI or 
other characteristics, but rather to illustrate the 
potential impact of consideration of flow rate. 
The results presented here suggest that future 
studies should examine this issue carefully 
when assessing associations between exposure 
and response using biomonitoring data, in 
order to reduce the potential for associations 
that represent “reverse causation.”
The analyses here suggest that future 
evaluations of potential associations between 
health outcomes and chemical exposures 
as reflected in urinary biomonitoring data 
should be assessed in the NHANES survey 
post-2008 not only on the basis of biomarker 
concentrations, but also on the basis of mass 
excretion rate (nanograms per hour and 
nanograms per kilogram per hour). Such 
evaluations should be structured using clear 
hypotheses regarding the relationship between 
exposure pathway, exposure metric, and 
health outcome of interest. Previous analyses 
of the cross-sectional NHANES data sets for 
associations between urinary concentrations 
of environmental chemicals and, for example, 
measures of obesity or health outcomes such 
as cardiovascular disease for which BMI is a 
risk factor (e.g., Bhandari et al. 2013; Carwile 
and Michels 2011; Eng et al. 2013; Hatch 
et al. 2008; LaKind et al. 2012; Melzer et al. 
2010, 2012; Trasande et al. 2012; Twum 
and Wei 2011), should be reassessed in the 
post-2008 NHANES data sets using the 
available flow rate data to calculate analyte 
mass excretion rates and be considered in 
this framework. Finally, in studies outside 
the NHANES framework that rely on spot 
urine samples, consideration should be given 
to collection of additional data on time of 
last urinary void and total void volume. These 
data will allow calculation of analyte excretion 
rate and permit evaluation of potential asso-
ciations with health outcomes on the basis of 
a more direct exposure metric as well as on 
the basis of urinary concentration.
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